Pirandamine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pirandamine
Pirandamine.png
Systematic (IUPAC) name
N,N-dimethyl-2-(1-methyl-4,9-dihydro-3H-indeno[2,3-c]pyran-1-yl)ethanamine
Clinical data
Legal status
  • Uncontrolled
Routes Oral
Identifiers
CAS number 57932-12-4
ATC code None
PubChem CID 431429
ChemSpider 381558
UNII WC6V8L1Z13 YesY
Chemical data
Formula C17H23NO 
Mol. mass 257.37 g/mol

Pirandamine (AY-23,713) is a tricyclic derivative which acts as a selective serotonin reuptake inhibitor (SSRI).[1][2][3] It was investigated in the 1970s as a potential antidepressant but clinical development was not commenced and it was never marketed.[1] Pirandamine is structurally related to tandamine, which, in contrast, is a selective norepinephrine reuptake inhibitor.[1][3]

See also[edit]

References[edit]

  1. ^ a b c Pugsley T, Lippmann W (May 1976). "Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities". Psychopharmacology 47 (1): 33–41. doi:10.1007/BF00428698. PMID 1085452. 
  2. ^ Lippmann W, Pugsley TA (August 1976). "Pirandamine, a relatively selective 5-hydroxytryptamine uptake inhibitor". Pharmacological Research Communications 8 (4): 387–405. doi:10.1016/0031-6989(76)90039-4. PMID 1088377. 
  3. ^ a b Lippmann W, Seethaler K (April 1977). "Effects of tandamine and pirandamine, selective blockers of biogenic amine uptake mechanisms, on gastric acid secretion and ulcer formation in the rat". Life Sciences 20 (8): 1393–400. doi:10.1016/0024-3205(77)90367-8. PMID 853871.